Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells

Biological Evaluation of a Novel Doxorubicin−Peptide Conjugate for Targeted Delivery to EGF Receptor-Overexpressing Tumor Cells

(2011) Shibin Ai et al.   MOLECULAR PHARMACEUTICS

Ultrasmall Gold−Doxorubicin Conjugates Rapidly Kill Apoptosis-Resistant Cancer Cells

(2010) Xuan Zhang et al.   BIOCONJUGATE CHEMISTRY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

EGFR Signaling and Drug Discovery

(2010) Georg Lurje et al.   ONCOLOGY

Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study

(2009) Sonia Aroui et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

ABC Efflux Pump-Based Resistance to Chemotherapy Drugs

(2009) Paul D. W. Eckford et al.   CHEMICAL REVIEWS

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

(2009) S. G. Aller et al.   SCIENCE

Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis

(2008) Michael Vibo Grandal et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells

(2008) Ken-ichi Ogawara et al.   JOURNAL OF CONTROLLED RELEASE

Doxorubicin Loaded pH-sensitive Micelle: Antitumoral Efficacy against Ovarian A2780/DOXR Tumor

(2008) Dongin Kim et al.   PHARMACEUTICAL RESEARCH